在无毒性重度抑郁症中REM参数:系统性审查和元分析
Mehmet K Arıkan1, Ömer Uysal2, Şakir Gıca3
1Kemal Arıkan Psychiatry Clinic, Istanbul, Turkey.
Sleep medicine reviews
|November 23, 2023
概括
这一元分析证实,与对照组相比,缩短REM延迟 (RL) 和增加REM密度 (RD) 是无药,无并发症的单极抑郁症患者的可靠电生理学标志物.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 睡眠医学 睡眠医学
背景情况:
- 快速眼动 (REM) 睡眠参数,包括REM延迟 (RL) 和REM密度 (RD),已被提出作为抑郁症的电生理学标志物.
- 以前的发现需要在同质样本中进行验证,特别是那些没有并发症和药物影响的样本.
研究的目的:
- 系统地审查和对现有文献进行元分析,以确定RL和RD在单极抑郁症无药,无并发症患者和健康对照患者之间是否有差异.
- 为RL和RD作为抑郁症客观生物标志物的实用性提供强有力的证据.
主要方法:
- 在PubMed和Web of Science数据库中进行了系统的搜索,截至2023年1月23日.
- 包括RL和RD在单极抑郁症患者和对照人群中比较的病例控制研究,使用随机效应模型分析数据.
- 使用元回归和埃格尔回归来评估效应大小,患者特征和出版偏差.
主要成果:
- 该元分析包括43篇符合条件的文章,包括46个RL和22个RD测量.
- 与对照组相比,单极抑郁症患者的RL显著缩短,RD增加.
- 通过埃格尔回归或漏斗图形不对称性,没有发现显著的出版偏差.
结论:
- 这些发现支持使用缩短REM延迟和增加REM密度作为单极抑郁症的电生理学标记.
- 这些结果与先前的文献一致,但通过在严格定义的无毒和无伴随性疾病个体样本中验证这些结果得到了加强.
关键词:
生物标志物生物标志物大型抑郁症主要是抑郁症.进行元分析分析.多重睡眠学术 (Polysomnography) 是一种多重睡眠学术.雷姆睡眠密度是指雷姆睡眠密度.雷姆睡眠时延迟时间睡眠电脑电图 (EEG) 是一个睡眠电图.更多相关视频
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
77
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
711
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
248
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
248
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
403
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
403
Antidepressant Drugs: Overview
516
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
516
Depression: Overview
254
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
254
Depressive Disorders: MDD and Dysthymia
136
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
136
Depressive Disorders: Etiology
103
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
103
